Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer.
Clin Cancer Res. 2016 May 15;22(10):2368-76. doi: 10.1158/1078-0432.CCR-15-1681. Epub 2015 Dec 7.
Clin Cancer Res. 2016.
PMID: 26644411
Free PMC article.
Clinical Trial.
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
Weekes CD, Von Hoff DD, Adjei AA, Leffingwell DP, Eckhardt SG, Gore L, Lewis KD, Weiss GJ, Ramanathan RK, Dy GK, Ma WW, Sheedy B, Iverson C, Miner JN, Shen Z, Yeh LT, Dubowy RL, Jeffers M, Rajagopalan P, Clendeninn NJ.
Weekes CD, et al. Among authors: leffingwell dp.
Clin Cancer Res. 2013 Mar 1;19(5):1232-43. doi: 10.1158/1078-0432.CCR-12-3529. Epub 2013 Feb 22.
Clin Cancer Res. 2013.
PMID: 23434733
Clinical Trial.
Item in Clipboard
Empirical Bayes estimates of subgroup effects in clinical trials.
Davis CE, Leffingwell DP.
Davis CE, et al. Among authors: leffingwell dp.
Control Clin Trials. 1990 Feb;11(1):37-42. doi: 10.1016/0197-2456(90)90030-6.
Control Clin Trials. 1990.
PMID: 2157579
Item in Clipboard
Cite
Cite